Stock listing
Apellis Pharmaceuticals, Inc.
Selected listing: APLS · NASDAQ · USD · US
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), Health Technology. Latest release Sep 17, 2026: Phase 3 Pediatric EMPAVELI Data Published in Clinical Journal…
- Ticker
- NASDAQ:APLS
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Apellis Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc. is a public company traded under the ticker APLS in the American market. Apellis focuses on developing innovative therapies to treat various diseases, leveraging advanced scientific research and technology.
Latest news from Apellis Pharmaceuticals, Inc.
Phase 3 Pediatric EMPAVELI Data Published in Clinical Journal of the American Society of Nephrology Show Reduction in Proteinuria and Stabilized Kidney Function in Adolescents with C3G or Primary IC-MPGN
September 17, 2026
Canada’s Drug Agency Issues Positive Reimbursement Recommendation for EMPAVELI® (pegcetacoplan) for the Treatment of C3G and Primary IC-MPGN
July 9, 2026
Biogen to Acquire Apellis, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology
March 30, 2026
Apellis Announces Mikael Dolsten, M.D., Ph.D., to Join Board of Directors
March 1, 2026
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
February 24, 2026
Events
Research Apellis Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc. company profile
View the public company page for Apellis Pharmaceuticals, Inc. on 6ix.
Apellis Pharmaceuticals, Inc. news
Read company news and market updates connected to Apellis Pharmaceuticals, Inc..
Apellis Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Apellis Pharmaceuticals, Inc..
Alternate listings
1JK:GETTEX
DE · EUR
Alternate listing for Apellis Pharmaceuticals, Inc.; the primary context on this page is APLS:NASDAQ.
1JK:TRADEGATE
DE · EUR
Alternate listing for Apellis Pharmaceuticals, Inc.; the primary context on this page is APLS:NASDAQ.
APLS:BOATS
US · USD
Alternate listing for Apellis Pharmaceuticals, Inc.; the primary context on this page is APLS:NASDAQ.
A2JAAW:LSX
DE · EUR
Alternate listing for Apellis Pharmaceuticals, Inc.; the primary context on this page is APLS:NASDAQ.
A2JAAW:LS
DE · EUR
Alternate listing for Apellis Pharmaceuticals, Inc.; the primary context on this page is APLS:NASDAQ.
APLS:BX
CH · CHF
Alternate listing for Apellis Pharmaceuticals, Inc.; the primary context on this page is APLS:NASDAQ.
1APLS:MIL
IT · EUR
Alternate listing for Apellis Pharmaceuticals, Inc.; the primary context on this page is APLS:NASDAQ.
1JK:FWB
DE · EUR
Alternate listing for Apellis Pharmaceuticals, Inc.; the primary context on this page is APLS:NASDAQ.
1JK:DUS
DE · EUR
Alternate listing for Apellis Pharmaceuticals, Inc.; the primary context on this page is APLS:NASDAQ.
1JK:MUN
DE · EUR
Alternate listing for Apellis Pharmaceuticals, Inc.; the primary context on this page is APLS:NASDAQ.
1JK:SWB
DE · EUR
Alternate listing for Apellis Pharmaceuticals, Inc.; the primary context on this page is APLS:NASDAQ.